Liminal BioSciences Inc. Gains 40%

Wed, Jul 12, 2023 at 07:38 PM

Liminal BioSciences Inc. (LMNL:NASDAQ) jumped higher at $8.33, representing a gain of 40%. On Wed, Jul 12, 2023, LMNL:NASDAQ hit a New 2-Week High of $8.33. The stock appeared on our News Catalysts scanner on Wed, Jul 12, 2023 at 08:05 AM in the 'AGREEMENT' category. From Wed, Jun 28, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days

About Liminal BioSciences Inc. (LMNL:NASDAQ)

Liminal Biosciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation, and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens.

Top 10 Gainers:

Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 93.37%
The NFT Gaming Company Inc. (NFTG:NASDAQ), 90.07%
Recursion Pharmaceuticals Inc. (RXRX:NASDAQ), 78.17%
Ault Alliance Inc Com (AULT:NYSEMKT), 60.91%
Freeline Therapeutics Holdings plc (FRLN:NASDAQ), 54.99%
Camber Energy, Inc. (CEI:NYSEMKT), 48.91%
InspireMD Inc. (NSPR:NASDAQ), 46.52%
AVROBIO, Inc. (AVRO:NASDAQ), 45.96%
Elys Game Technology Corp. (ELYS:NASDAQ), 43.7%
Liminal BioSciences Inc. (LMNL:NASDAQ), 40%